title: ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer.
abstract: Background. The prognostic significance of ERG expression in prostate cancer (PCA) has generated mixed results. We sought to investigate the prognostic significance of ERG expression in a localized cohort of men with PCA. Material and Methods. We investigated ERG protein expression in a cohort of 198 men with localized PCA. ERG expression was correlated with patients' clinical outcome and several pathological parameters, including Gleason score (GS), pathological stage, surgical margin, and extra-capsular extension. Results. ERG expression was detected in 86/198 (43.4%) patients exclusively in neoplastic epithelium. Overall, ERG mean expression intensity was 1.01 ± 1.27 versus 0.37 ± 0.83 in acinar PCA compared to foamy type PCA (P < 0.001). In HGPIN, ERG intensity levels were comparable to those in foamy type PCA (0.13 ± 0.56) but significantly lower than those in acinar PCA (P < 0.001). ERG expression was significantly associated with extra-prostatic extension and higher pathological stage and showed a trend toward seminal vesicle invasion. Herein, ERG expression was documented in 50/131 (38.1%) patients with pT2 versus 30/55 (54.5%) patients with pT3 (P = 0.04). ERG association with higher pathological stage was more pronounced in patients with GS > 7. Grouping patients into those with GS ≤ 7 versus >7, there was no significant association between ERG expression and GS. Similarly, no association was present in relation to either surgical margins or postsurgical serum PSA levels. Conclusion. We report significant association between ERG protein levels and extra-prostatic extension and higher pathological stage. ERG expression is not associated with adverse clinical outcome and is of limited prognostic value in localized PCA.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada T2V 1P9.
authors.forename: Liang Hong
authors.initials: LH
authors.lastname: Teng
authors.forename: Cheng
authors.initials: C
authors.lastname: Wang
authors.forename: Michael
authors.initials: M
authors.lastname: Dolph
authors.forename: Bryan
authors.initials: B
authors.lastname: Donnelly
authors.forename: Tarek A
authors.initials: TA
authors.lastname: Bismar
references.citation: BJU Int. 2011 Feb;107(3):477-85
references.pmid: 20590547
references.citation: Am J Surg Pathol. 2011 Jul;35(7):1014-20
references.pmid: 21677539
references.citation: Cancer Res. 2006 Apr 1;66(7):3396-400
references.pmid: 16585160
references.citation: Clin Cancer Res. 2010 Feb 15;16(4):1340; author reply 1340
references.pmid: 20145164
references.citation: Cancer Res. 2008 Sep 15;68(18):7541-9
references.pmid: 18794142
references.citation: Clin Cancer Res. 2009 Feb 15;15(4):1376-83
references.pmid: 19228738
references.citation: BJU Int. 2010 Aug;106(3):418-23
references.pmid: 20002675
references.citation: Mod Pathol. 2008 Dec;21(12):1451-60
references.pmid: 18500259
references.citation: J Pathol. 2007 May;212(1):91-101
references.pmid: 17385188
references.citation: Clin Cancer Res. 2008 Jun 1;14(11):3395-400
references.pmid: 18519769
references.citation: Cancer Biol Ther. 2011 Mar 15;11(6):562-6
references.pmid: 21178509
references.citation: Genes Chromosomes Cancer. 2007 Nov;46(11):972-80
references.pmid: 17654723
references.citation: Cancer Res. 2006 Sep 1;66(17):8337-41
references.pmid: 16951139
references.citation: Eur J Cancer. 2012 Mar;48(4):538-46
references.pmid: 22300588
references.citation: Neoplasia. 2010 Jul;12(7):590-8
references.pmid: 20651988
references.citation: BMC Cancer. 2008 Aug 11;8:230
references.pmid: 18694509
references.citation: Am J Surg Pathol. 2007 Jun;31(6):882-8
references.pmid: 17527075
references.citation: Clin Cancer Res. 2009 Oct 15;15(20):6398-403
references.pmid: 19825963
references.citation: Mod Pathol. 2009 Aug;22(8):1083-93
references.pmid: 19407851
references.citation: Oncogene. 2007 Jul 5;26(31):4596-9
references.pmid: 17237811
references.citation: Mod Pathol. 2012 Mar;25(3):471-9
references.pmid: 22080055
references.citation: Prostate Cancer Prostatic Dis. 2010 Sep;13(3):228-37
references.pmid: 20585344
references.citation: Am J Surg Pathol. 2011 Mar;35(3):432-41
references.pmid: 21317715
references.citation: Mod Pathol. 2009 Mar;22(3):359-65
references.pmid: 19151660
references.citation: Mod Pathol. 2011 Jun;24(6):820-8
references.pmid: 21336263
references.citation: Br J Cancer. 2007 Dec 17;97(12):1690-5
references.pmid: 17971772
references.citation: Cancer Res. 2009 Feb 15;69(4):1400-6
references.pmid: 19190343
references.citation: Clin Cancer Res. 2007 Sep 1;13(17):5103-8
references.pmid: 17785564
references.citation: Cancer Biol Ther. 2009 Jan;8(2):125-30
references.pmid: 19029822
references.citation: Science. 2005 Oct 28;310(5748):644-8
references.pmid: 16254181
references.citation: Br J Cancer. 2010 Feb 16;102(4):678-84
references.pmid: 20104229
references.citation: Clin Cancer Res. 2011 Sep 15;17(18):5878-88
references.pmid: 21791629
references.citation: Am J Surg Pathol. 2005 Sep;29(9):1228-42
references.pmid: 16096414
references.citation: Genes Chromosomes Cancer. 2006 Jul;45(7):717-9
references.pmid: 16575875
references.citation: Cancer Res. 2008 Jan 1;68(1):73-80
references.pmid: 18172298
references.citation: Mod Pathol. 2011 Aug;24(8):1128-38
references.pmid: 21499236